Manufacturing a vaccine for West Nile virus
Official title: Task V30: GMP Manufacturing of WNV Vaccine
Funded at Advanced Bioscience Laboratories, INC. · NIH-10794913 · Data updated 2026-11-12
This study is working on creating a safe and effective vaccine to protect people from the West Nile virus and other similar infections, so that one day you might have a way to stay healthy against these diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2023 |
| Award (this year) | $1,430,843 |
| NIH project number | 272201800009I-P00001-759302200001-1 |
| Project ID | NIH-10794913 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of exposure to West Nile virus, particularly those living in areas where the virus is prevalent.
✕Less likely to help
Patients who are not at risk of West Nile virus exposure or those who have already been vaccinated against it may not receive any benefit from this research.
What this research studies
This research focuses on the development and manufacturing of a vaccine for the West Nile virus (WNV) and other infectious diseases. It involves creating biologics that meet stringent regulatory standards for safety and efficacy, including compliance with current Good Manufacturing Practices (cGMP). The project includes various stages such as product development planning, feasibility assessments, and toxicology studies to ensure the vaccine is safe for human use. Patients may benefit from the eventual availability of a vaccine that can protect against WNV and similar infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to a safe and effective vaccine that protects patients from West Nile virus infections.
How similar studies have gone: Other research has shown success in developing vaccines for similar infectious diseases, indicating that this approach has potential for success.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Hong, Wang — Advanced Bioscience Laboratories, INC.
- Study coordinator: Hong, Wang
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.